The Metabolic Phenotype of Prostate Cancer
Open Access
- 19 June 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 7, 131
- https://doi.org/10.3389/fonc.2017.00131
Abstract
Prostate cancer is the most common non-cutaneous cancer in men in the United States. Cancer metabolism has emerged as a contemporary topic of great interest for improved mechanistic understanding of tumorigenesis. Prostate cancer is a disease model of great interest from a metabolic perspective. Prostatic tissue exhibits unique metabolic activity under baseline conditions. Benign prostate cells accumulate zinc and this excess zinc inhibits citrate oxidation and metabolism within the citric acid cycle, effectively resulting in citrate production. Malignant cells, however, actively oxidize citrate and resume more typical citric acid cycle function. Of further interest, prostate cancer does not exhibit the Warburg effect, an increase in glucose uptake, seen in many other cancers. These cellular metabolic differences and others are of clinical interest as they present a variety of potential therapeutic targets. Furthermore, understanding of the metabolic profile differences between benign prostate versus low and high-grade prostate cancers also represents an avenue to better understand cancer progression and potentially develop new diagnostic testing. In this paper, we review the current state of knowledge on the metabolic phenotypes of prostate cancer.Keywords
Funding Information
- U.S. Department of Defense (PC150408)
This publication has 50 references indexed in Scilit:
- Metabolomic signatures of aggressive prostate cancerThe Prostate, 2013
- Fatty Acid Synthase Is a Key Target in Multiple Essential Tumor Functions of Prostate Cancer: Uptake of Radiolabeled Acetate as a Predictor of the Targeted Therapy OutcomePLOS ONE, 2013
- Toward the Detection of Prostate Cancer in Urine: A Critical AnalysisJournal of Urology, 2013
- Deprivation of arginine by recombinant human arginase in prostate cancer cellsJournal of Hematology & Oncology, 2012
- Human prostate cancer ZIP1/zinc/citrate genetic/metabolic relationship in the TRAMP prostate cancer animal modelCancer Biology & Therapy, 2011
- Novel Lipogenic Enzyme ELOVL7 Is Involved in Prostate Cancer Growth through Saturated Long-Chain Fatty Acid MetabolismCancer Research, 2009
- Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent ApoptosisCancer Research, 2009
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- Androgen Resistance — The Clinical and Molecular SpectrumNew England Journal of Medicine, 1992
- THE METABOLISM OF TUMORSThe American Journal of the Medical Sciences, 1931